Skip to main content

Advertisement

Table 1 Statistical analysis of patient characteristics in the intravenous to oral therapy and intravenous therapy groups

From: Impact of switching from intravenous to oral linezolid therapy in Japanese patients: a retrospective cohort study

  Intravenous to oral therapy group
(n = 21)
Intravenous therapy group
(n = 52)
p-value
Age (years) 64 ± 19 65 ± 16 0.69
Male (n [%]) 19 (90.5) 40 (76.9) 0.18
White blood cell count 8.8 ± 3.8 10.6 ± 5.7 0.20
CRP 6.9 ± 4.8 8.6 ± 6.7 0.20
Platelet count 25.5 ± 9.7 23.2 ± 11.9 0.45
Indication (n [%])
 Lower respiratory infection 7 (33.3) 13 (25.0) 0.47
 Skin, soft tissue, bone or joint infection 7 (33.3) 20 (38.5) 0.68
 Urinary/genital tract infection 2 (9.5) 3 (5.8) 0.57
 Intra-abdominal infection 1 (4.8) 2 (3.8) 0.86
 Other/unknown 4 (19.0) 14 (26.9) 0.48
  1. CRP C-reactive protein; data are the mean ± standard deviation
  2. P-values were calculated based on Students t-test or Welch’s t-test for continuous variables and chi-squared analysis for discrete variables